What's new

Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/05/2025 Positive

Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/05/2025 Positive

Jun 24, 2025 - 19:10
 0
Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/05/2025 Positive
Orphan designation: Tertomotide Treatment of progressive supranuclear palsy, 22/05/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Equine polyclonal immunoglobulin F(ab')2 fragments against r...

Next Article

Orphan designation: recombinant human ectonucleotide pyrophosphatase/phosphodies...

Related Posts

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0

Medicine shortage communication (MSC): Fiasp PumpCart a...

May 12, 2025  0

Human medicines European public assessment report (EPAR): Entresto, sacubitril,valsartan, Date of authorisation: 19/11/2015, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

Jun 23, 2025  0